MARKET

GRAL

GRAL

Grail Inc
NASDAQ
50.21
-51.32
-50.55%
After Hours: 49.39 -0.82 -1.63% 19:59 02/20 EST
OPEN
49.66
PREV CLOSE
101.53
HIGH
56.75
LOW
48.00
VOLUME
15.48M
TURNOVER
--
52 WEEK HIGH
118.84
52 WEEK LOW
20.44
MARKET CAP
1.96B
P/E (TTM)
-4.5191
1D
5D
1M
3M
1Y
5Y
1D
GRAIL: A Major Trial Disappointment
Seeking Alpha · 1d ago
Trending stocks as Wall Street ends higher despite cooling growth, Supreme Court tariff ruling
Seeking Alpha · 1d ago
5 Analysts Assess GRAIL: What You Need To Know
Benzinga · 2d ago
This once-hot cancer-detection company’s stock got cut in half after a failed trial
MarketWatch · 2d ago
Grail Price Target Cut to $80.00/Share From $105.00 by Canaccord Genuity
Dow Jones · 2d ago
Grail Is Maintained at Buy by Canaccord Genuity
Dow Jones · 2d ago
Canaccord Genuity Maintains Buy on GRAIL, Lowers Price Target to $80
Benzinga · 2d ago
These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More
Barron‘s · 2d ago
More
About GRAL
Grail, Inc. is a healthcare company focused on saving lives and shifting the paradigm in early cancer detection. The Company is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its multi-cancer early detection test, the Galleri test, is a commercially available screening test for early detection of multiple types of cancer. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer.

Webull offers Grail Inc stock information, including NASDAQ: GRAL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRAL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRAL stock methods without spending real money on the virtual paper trading platform.